IMMTEK in short

National Swedish R&D Program on Immunotechnology

A parallell  activity to the Nordic NordIMM Program was the Swedish R&D Program on Immunotechnology. Both activities addressed the rapidly emerging technology platform of Immunotechnology when it was at its most important phase in establishing IPR protection.

Organization and Finance

Programme Coordination:

SBF - Biotechnology Research Foundation (Gunnar Hörnsten)

Steering Committee:

Per Vretblad, Pharmacia Biotech

Bertil Ekström, Astra Arcus

Svante Svensson, Sockerbolaget

Hans Söderlund, VTT

Erik Lundgren, Umeå University

Margareta Bervenmark, NUTEK Swedish National Board for Industrial and Technical Development

Finance:

 Shared costs Industry and Swedish National Board for Industrial and Technical Development (NUTEK contributed 18 MSEK)

Duration: 1994-1997

Participants:

Astra Arcus

Astra Draco

Astra Pain Control

BioGaia

Bioinvent Therapeutics

Eurodiagnostica

Karolinska Institutet (Marianne von Hage-Hamsten and Britta Wahren)

Kemila

Lund University (Carl Borrebaeck, Bo Mattiasson and Gillis Johansson)

Pharmacia Oncology

Pharmacia & Upjohn Biopharmaceuticals

Pharmacia & Upjohn Biotech

Pharmacia & Upjohn Diagnostics

Pharmacia Biosensor

Royal Institute of Technology (Stefan Ståhl)

SBF Biotechnology Research Foundation

SIK

Swedish Agricultural University (Martin Lindberg)

Swedish Meat Research Institute

Uppsala University (Ulf Landegren)